BP464

プレドニゾロン

British Pharmacopoeia (BP) Assay Standard

• 別名: 1,4-プレグナジエン-11β,17α,21-トリオール-3,20-ジオン, 1-デヒドロコルチゾール, 1-デヒドロヒドロコルチゾン, 11β,17α,21-トリヒドロキシ-1,4-プレグナジエン-3,20-ジオン
• 実験式（ヒル表記法）: C₂₁H₂₈O₅
• CAS番号: 50-24-8
• 分子量: 360.44
• Beilstein: 1354103
• EC Number: 200-021-7
• MDL番号: MFCD00003649
• UNSPSCコード: 41116107
• NACRES: NA.24

特性

• グレード: pharmaceutical primary standard
• APIファミリー: prednisolone
• 形状: crystalline
• シェルフライフ: limited shelf life, expiry date on the label
• メーカー／製品名: BP
• mp: 240 °C (dec.) (lit.)
• アプリケーション: pharmaceutical; pharmaceutical small molecule
• フォーマット: neat
• SMILES記法: O=C1C=C[C@@]2(C)C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])CC[C@]4(O)C(CO)=O)=C1
• InChI: 1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1
• InChI Key: OIGNJSKKLXVSLS-VWUMJDOOSA-N
• 遺伝子情報: human ... NR3C1(2908)

詳細

詳細

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

アプリケーション

Prednisolone BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Estriol Cream

Prednisolone Sodium Phosphate Ear Drops

Prednisolone Sodium Phosphate Eye Drops

Prednisolone Tablets

Prednisolone Soluble Tablets

Prednisolone Enema

Prednisolone Sodium Phosphate Oral Solution

Prednisolone Gastro-resistant Tablets

その他情報

Sales restrictions may apply.

安全性情報

• ピクトグラム: GHS08
• シグナルワード: Danger
• 危険有害性情報: H360FD
• 注意書き: P201 - P202 - P280 - P308 + P313 - P405 - P501
• 危険有害性の分類: Repr. 1B
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 2